WAM
NVAX icon

Wolverine Asset Management’s Novavax NVAX Stock Holding History

Wolverine Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,400
Closed -$220K – 2020
2022
Q4 		$220K Buy
21,400
+5,700
+36% +$101K ﹤0.01% 1131
2022
Q3 		$285K Hold
15,700
– – ﹤0.01% 1170
2022
Q2 		$807K Buy
15,700
+10,000
+175% +$518K 0.01% 857
2022
Q1 		$419K Buy
5,700
+5,600
+5,600% +$499K ﹤0.01% 1024
2021
Q4 		$14K Hold
100
– – ﹤0.01% 1797
2021
Q3 		$20K Hold
100
– – ﹤0.01% 1634
2021
Q2 		$21K Hold
100
– – ﹤0.01% 1895
2021
Q1 		$18K Buy
+100
New +$19.9K ﹤0.01% 1779
2019
Q2 		– Sell
-355
Closed -$3K – 1552
2019
Q1 		$3K Buy
355
+55
+18% +$1.74K ﹤0.01% 1307
2018
Q4 		$11K Buy
+300
New +$11.6K ﹤0.01% 1530
2017
Q1 		– Sell
-1,535
Closed -$38K – 1327
2016
Q4 		$38K Sell
1,535
-465
-23% -$13.6K ﹤0.01% 1035
2016
Q3 		$83K Buy
2,000
+800
+67% +$103K ﹤0.01% 996
2016
Q2 		$174K Buy
+1,200
New +$138K ﹤0.01% 894

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Asset Management's NVAX Position: Q1 2024 in Review

Wolverine Asset Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 22,767 shares — an estimated $106K sold.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and held it in 11 quarters. The position peaked at $2.43M in Q1 2023. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Wolverine Asset Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 22,767 Novavax shares in Q1 2024, an estimated $106K.
  • Wolverine Asset Management first reported a position in Novavax in Q4 2018 and held it in 11 quarters.
  • Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.